| Towards understanding socially influenced vaccination decision making: An integrated model of multiple criteria belief modelling and social network analysis L Ni, Y Chen, O de Brujin European Journal of Operational Research 293 (1), 276-289, 2021 | 60 | 2021 |
| Explainable artificial intelligence for digital forensics: opportunities, challenges and a drug testing case study L Kelly, S Sachan, L Ni, F Almaghrabi, R Allmendinger, Y Chen Digital Forensic Science, 2020 | 22 | 2020 |
| Visualising internal migration flows across local authorities in England and Wales Y Chen, L Ni, L Ospina-Forero Environment and Planning A: Economy and Space 53 (4), 616-618, 2021 | 10 | 2021 |
| Visualising regional disparities in the risk of COVID-19 at different phases of lockdown in England YW Chen, L Ni, DL Xu, JB Yang Environment and Planning A: Economy and Space 53 (5), 883-886, 2021 | 4 | 2021 |
| 1753P Cost-effectiveness (CE) of nivolumab (NIVO) as adjuvant treatment of muscle invasive urothelial carcinoma at high risk of recurrence (MIUC-HR) in France MS Negrier, FP Colrat, J Bonastre, C Chamielec, S Teitsson, C Knight, ... Annals of Oncology 33, S1339-S1340, 2022 | 1 | 2022 |
| P37 Impact of Method for Modelling Distant Recurrence (DR) on Cost-Effectiveness (CE) of Nivolumab (NIVO) as an Adjuvant Treatment of Muscle-Invasive Urothelial Carcinoma (MIUC … J Bonastre, S Négrier, F Colrat, C Chamielec, S Teitsson, C Knight, L Ni, ... Value in Health 25 (12), S9, 2022 | | 2022 |
| EE334 Cost-Effectiveness Analysis of Nivolumab as an Adjuvant Treatment of Muscle-Invasive Urothelial Carcinoma at High Risk of Recurrence in Greece L Ni, F Diamantogiannis, S Teitsson, C Knight Value in Health 25 (12), S120, 2022 | | 2022 |